Certuity’s Globus Medical GMED Stock Holding History

Certuity’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$428K	Buy	5,412 +1,770	+49%	+$150K	0.02%	398
2026 Q1	$314K	Buy	+3,642	New	+$327K	0.02%	439

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Certuity's GMED Position: Q2 2026 in Review

Certuity increased its Globus Medical (GMED) stake by 49% in Q2 2026, buying an estimated $150K and bringing the position to 5,412 shares worth $428K. The position accounts for 0.02% of the portfolio, ranked #398.

Certuity first reported a position in GMED in Q1 2026 and has held it in 2 quarters since. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Certuity held 5,412 shares of Globus Medical worth $428K as of Q2 2026.
Certuity bought 1,770 Globus Medical shares in Q2 2026, an estimated $150K.
Globus Medical made up 0.02% of Certuity's portfolio in Q2 2026, its #398 holding.
Certuity first reported a position in Globus Medical in Q1 2026 and has held it in 2 quarters since.
600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.